Perigon Wealth Management LLC Makes New $3.32 Million Investment in Danaher Corporation $DHR

Perigon Wealth Management LLC purchased a new position in Danaher Corporation (NYSE:DHRFree Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 4,607 shares of the conglomerate’s stock, valued at approximately $3,317,000.

A number of other institutional investors have also recently made changes to their positions in DHR. Sivia Capital Partners LLC boosted its stake in Danaher by 6.3% during the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after buying an additional 119 shares during the last quarter. First Trust Advisors LP raised its holdings in shares of Danaher by 34.5% during the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock worth $10,947,000 after acquiring an additional 14,217 shares in the last quarter. Main Street Financial Solutions LLC boosted its position in shares of Danaher by 40.2% during the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock valued at $610,000 after acquiring an additional 886 shares during the last quarter. Ieq Capital LLC grew its holdings in shares of Danaher by 64.2% in the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after purchasing an additional 29,592 shares in the last quarter. Finally, HUB Investment Partners LLC increased its position in Danaher by 30.7% in the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock worth $273,000 after purchasing an additional 325 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on DHR. Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Guggenheim reduced their target price on shares of Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. HSBC decreased their target price on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Stifel Nicolaus dropped their price target on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Finally, JPMorgan Chase & Co. decreased their price objective on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Get Our Latest Stock Analysis on Danaher

Danaher Trading Down 0.0%

DHR stock opened at $202.44 on Tuesday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock has a market capitalization of $142.31 billion, a price-to-earnings ratio of 35.96, a price-to-earnings-growth ratio of 2.52 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The firm’s fifty day simple moving average is $193.52 and its two-hundred day simple moving average is $192.67.

Danaher (NYSE:DHRGet Free Report) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same quarter last year, the business earned $0.77 EPS. The business’s revenue was up 5.5% on a year-over-year basis. As a group, analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.